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Abstract
Objective: Evaluation of the interaction between alcohol intake and cofactors
[hepatitis B virus (HBV), hepatitis C virus (HCV), body mass index] and
coffee consumption on the risk of cirrhosis. Design: Seven hundred and forty-
nine consecutive patients with chronic liver disease referring to units for liver
or alcohol diseases in Italy during a 6-months period. Teetotalers were
excluded. The odds ratios (OR) for cirrhosis were evaluated using chronic
hepatitis cases as the control group. Results: An alcohol intake of more than
3 units/day resulted associated with the likelihood of cirrhosis both in males
(OR 4.3; 95% CI = 2.5–7.3) and in females (OR 5.7; 95% CI = 2.3–14.5).
A multiplicative interaction on the risk of cirrhosis between risky alcohol
intake and HBsAg or HCV-Ab/HCV-RNA positivity was observed. A reduc-
tion of cirrhosis risk was observed in subjects consuming more than 3 alcohol
units/day with increasing coffee intake. The OR for the association with
cirrhosis decreased from 2.3 (95% CI = 1.2–4.4) in subjects drinking 0–2 cups
of coffee/day to 1.4 (95% CI = 0.6–3.6) in those drinking more than 2 cups/
day. Conclusions: In subjects with an alcohol intake 43 units/day the coex-
istence of HBV or HCV multiplies the risk of cirrhosis. Coffee represents a
modulator of alcoholic cirrhosis risk.
It is well known that ethanol is a major risk factor for
chronic liver disease. It has been shown repeatedly that in
the general Italian population, the amount of alcohol
intake that causes liver damage is 43 units/day (1–3).
Moreover, ethanol may be an important cofactor for the
progression of chronic liver damage when it is present
together with other causative agents. It has been shown
that hepatitis C virus (HCV) chronic infection interacts
multiplicatively with alcohol intake in determining cir-
rhosis (4), while the role of hepatitis B virus (HBV)
chronic infection is still being debated (5). In the past
years, the role of obesity as an important cofactor of
cirrhosis in alcoholics has also been stressed (6) Finally, it
has also been shown that an inverse relation exists
between coffee intake and the risk of cirrhosis, and that
coffee has a favourable effect on alcohol-related cirrhosis
risk (7–9). However, all the reported studies have eval-
uated the interaction of alcohol with a single cofactor
[i.e. HCV or body mass index (BMI) or coffee], whereas
studies assessing the role of various cofactors in the same
cohort of alcoholic patients are lacking. Moreover, the
interaction, if any, between HBsAg and alcohol is still
unclear.
The aim of this paper was to evaluate in the same
setting of patients the interaction between alcohol intake
and various cofactors such as chronic HCV infection,
chronic HVB infection and BMI on the risk of cirrhosis.
The effect of coffee consumption on the risk of alcoholic
cirrhosis has also been assessed.
Patients and methods
During a 6-month period (January–June 2007), all con-
secutive patients with chronic liver disease referring to a 9
units of internal medicine and/or gastroenterology for
the management of their pathology were recruited. These
units were distributed homogeneously across Italy. Tee-
totalers were excluded. For each patient, demographical,
clinical and aetiological data were recorded using a
precoded questionnaire. The amount of alcohol intake
was determined using a standard questionnaire contain-
ing information on the daily alcohol intake of various
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alcoholic beverages, according to previously codified
methods by us and other groups (10, 11). One alcoholic
unit corresponds to a glass of wine, a can of beer or a
measure of spirits, and contains 12–13 g of ethanol. For
alcohol intake, we also considered the type of beverage
used more frequently, the duration of use and the
modalities of ingestion (at fasting, during meals, etc.).
We also collected the amount of lifetime coffee consump-
tion (at least during the last 10 years), using as the unit of
measure the number of cups of ‘espresso’ coffee per day.
The use of other types of coffee was absent in our cases.
Demographical data also included the evaluation of
comorbidities such as diabetes, hypertension, dyslipidae-
mia or others. Patients who consumed drugs for the
nervous system (or other well-known hepatotoxic drugs)
were excluded from the study owing to their possible
interference with liver damage.
Hepatitis B surface antigen and antibodies to HCV
(anti-HCV) were determined using enzyme-linked im-
munosorbent assays. HCV-RNA was assessed by poly-
merase chain reaction. Chronic hepatitis was diagnosed
on the basis of liver histology or in the presence of
persistently (46 months) abnormal ALT without clinical,
biochemical and ultrasound markers of cirrhosis. Cir-
rhosis was diagnosed by liver biopsy or in the presence of
clinical, biochemical and ultrasound signs (12).
Statistical analysis
The odds ratio (OR) of cirrhosis and their 95% con-
fidence intervals were evaluated using chronic hepatitis
cases as the control group . Interaction may be additive
or multiplicative. Additive interaction means that the
observed joint effect of two factors on the disease
incidence (in this case cirrhosis) exceeds the sum of the
effect of exposure to each single factor minus 1. Multi-
plicative interaction means that the observed joint effect
of two factors on the disease incidence exceeds the
product of the effect of exposure to each single factor.
To evaluate the interaction between alcohol intake and
cofactors, subjects unexposed to either factor were taken
as the reference category for all calculations.
We dichotomized alcohol intake as 1–3 units/day (low
or moderate drinkers) and 43 units/day (heavy drin-
kers), according to the threshold of 3 units of alcohol
considered necessary for the development of alcohol-
mediated injury (13).
Results
A total of 749 cases were enrolled during the study
period. A preponderance (66.3%) of males was observed.
The majority of subjects (63.4%) reported low or mod-
erate alcohol intake (1–3 units/day); nearly a quarter
admitted a very heavy alcohol intake (45 units/day).
The proportion of subjects who were HBsAg positive
was 8.1%, while 53.0% of the subjects were anti-HCVand
HCV-RNA positive. Chronic hepatitis was diagnosed in
81.8% of cases (Table 1). An alcohol intake of 43 units/
day resulted associated with the likelihood of cirrhosis in
both males (OR = 4.3; 95% CI = 2.5–7.3) and females
(OR = 5.7; 95% CI = 2.3–14.5).
The amount of 3 units/day resulted unassociated in
both sexes (Table 2).
A multiplicative interaction between alcohol intake
and HBV- or HCV-related disease is observed. In fact,
excluding subjects who were HCV/HCV-RNA positive,
the OR of cirrhosis for joint exposure to 43 alcohol
units/day and HBsAg positivity was 4.8 (95% CI = 1.9–
12.4), while the OR for exposure to only 43 alcohol
units/day was 2.4 (95% CI = 1.3–4.2) and the OR for
exposure to only HBsAg positivity was 0.2 (95%
Table 1. Characteristics of 749 enrolled patients
Characteristics %
Sex
Males 66.3
Females 33.7
Age distribution (years)
o45 37.0
46–65 39.5
465 23.5
BMI
o25 42.4
425 57.6
Number of drinks/day
1–3 63.4
4 7.6
5 3.6
6–10 13.4
410 12.0
HBsAg1 8.1
HCVAb1/HCV-RNA1 53.0
Chronic hepatitis 81.8
Cirrhosis 18.2
BMI, body mass index; HCV, hepatitis C virus.
Table 2. Progression from chronic hepatitis to cirrhosis according to amount of alcohol intake stratified by sex
Number of drinks/day
Males (n= 510) Females (n= 259)
Chronic hepatitis Cirrhosis OR (95% CI) Chronic hepatitis Cirrhosis OR (95% CI)
1–2 n= 192 n= 23 1 n= 190 n= 14 1
3 n= 49 n= 7 1.2 (0.5–2.9) n= 17 n= 1 0.8 (0.1–6.5)
43 n= 158 n= 81 4.3 (2.5–7.3) n= 26 n= 11 5.7 (2.3–14.5)
Crude odds ratios (O.R.) derived by univariate analysis.
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CI = 0.1–1.1). Similarly, excluding HBsAg-positive sub-
jects, the OR of cirrhosis for joint exposure to 43 alco-
hol units/day and HCV/HCV-RNA positivity was 3.2
(95% CI = 1.8–5.7), while the OR for exposure to only
43 alcohol units/day was 2.4 (95% CI = 1.3–4.2) and the
OR for exposure to only HCV/HCV-RNA positivity was
0.2 (95% CI = 0.2–0.8). No interaction was found in
subjects exposed to the joint effect of obesity and risky
alcohol intake (OR = 2.0; 95% CI = 0.7–5.6) (Table 3).
Other aspects such as the type of alcoholic beverage used,
the duration of use and the presence of comorbidities did
not significantly influence the results. A reduction in
cirrhosis risk was observed in subjects consuming 43
alcohol units/day with increasing coffee intake. The OR
for the association with cirrhosis decreased from 2.3
(95% CI = 1.2–4.4) in subjects drinking 0–2 cups of
coffee/day to 1.4 (95% CI = 0.6–3.6) in those drinking
42 cups/day. (Table 4).
Discussion
Firstly, the present findings confirm previous studies
(1–3) showing that the amount of alcohol intake that
causes liver damage is 43 units/day. In order to evaluate
the interaction between alcohol intake and cofactors on
the risk of cirrhosis, we have used an internal control,
which is the best control group. Cases (i.e. cirrhotic
patients) and controls (i.e. chronic hepatitis cases) were
subjects extracted from the same population (i.e. subjects
with chronic liver disease) and thus exposed to the same
potential selective factors. In a case–control study com-
parability between cases and controls is the crucial factor,
which means avoidance of potential selective factors
regarding the enrollment of cases and controls.
The present findings confirm previous report that in
subjects with risky alcohol intake, the coexistence of
HCV infection multiplies the risk of cirrhosis (4). Several
lines of evidence provide the biological plausibility for
this epidemiological finding.
Firstly, both HCV and alcohol may stimulate hepatic-
oxidative stress, which leads to the activation of liver
fibrogenic cells, and the consequent acceleration of
fibrogenesis (14–16).
Secondly, immune response is affected by alcohol;
finally, alcohol may promote apoptosis in hepatocytes
infected by HCV (17–19).
The observed joint effect in terms of multiplicative
interaction between alcohol intake and HBV infection on
the risk of cirrhosis is a new finding. However, a clear
biological plausibility for that has not yet been provided.
It may be presumed that the mechanisms enhancing liver
damage are similar to those involved in HCV infection
(i.e. enhanced oxidative stress, interaction with immune
response and activation of pro-inflammatory cytokine
pathways).
An interesting finding, even though not new is that of
the protective effect of coffee on alcohol-related cirrhosis
risk. There is a continuum of clinical and epidemiologi-
cal evidence to support a favourable effect of coffee on
liver function (8) and liver disease, including cirrhosis
(20) and hepatocellular carcinoma (21). There is some
concern that the inverse relation observed between coffee
intake and liver disease may be spurious, as a conse-
quence of the fact that subjects with liver disease may
reduce their coffee consumption. Hypothetically, some
persons with liver disease might have reduced coffee
intake or quit drinking coffee, thus spuriously increasing
the risk of the referral group. However, as the coffee
consumption concerned the last 10 years and the control
group was represented by subjects with chronic liver
disease (and thus exposed to similar selective factors than
cases), this bias has resulted likely avoided. Various
components of coffee have been related to act a protective
effect including caffeine (via adenosine receptor antago-
nists or antioxidant action), cafertol (via induction of the
Table 3. Interaction between alcohol intake and cofactors in the
progression from chronic hepatitis to cirrhosis
Cofactor
Chronic
hepatitis Cirrhosis
Likelihood of
cirrhosis
OR (95% CI)
HBsAg and alcohol (excluding HCV1cases)
HBsAg/1–3 drinks n= 143 n= 25 1
HBsAg1/1–3 drinks n= 37 n= 1 0.2 (0.1–1.1)
HBsAg/4 3 drinks n= 87 n= 36 2.4 (1.3–4.2)
HBsAg143 drinks n= 13 n= 11 4.8 (1.8–12.4)
HCV and alcohol (excluding HBsAg1)
HCV/1–3 drinks n= 143 n= 25 1
HCV1/1–3 drinks n= 260 n= 20 0.4 (0.2–0.8)
HCV/4 3 drinks n= 87 n= 36 2.4 (1.3–4.2)
HCV1/43 drinks n= 75 n= 42 3.2 (1.8–5.7)
BMI and alcohol (excluding HBsAg1and HCV1)
BMIo30/1–3 drinks n= 110 n= 22 1
BMIZ30/1–3 drinks n= 32 n= 3 0.5 (0.1–1.7)
BMIo30/43 drinks n= 69 n= 27 1.3 (1.0–3.7)
BMIZ30/4 3 drinks n= 17 n= 7 2.0 (0.7–5.6)
Table 4. The effect of coffee intake on the progression from chronic hepatitis to liver cirrhosis according to the amount of alcohol intake
(HBsAg1 and HCV1 subjects were excluded from the analysis)
Cups of coffee/day
0–2 42
Chronic hepatitis Cirrhosis OR (95% CI) Chronic hepatitis Cirrhosis OR (95% CI)
Number of alcohol drinks/day
1–3 n= 101 n= 21 1 n= 40 n= 3 0.4 (0.1–1.3)
43 n= 59 n= 28 2.3 (1.2–4.4) n= 27 n= 8 1.4 (0.6–3.6)
Liver International (2010)
c 2010 John Wiley & Sons A/S 869
Stroffolini et al. Interaction of alcohol intake and cofactors
synthesis of glutathione, a cellular protective factor) and
anti-oxidant substances from coffee beans, such as flavo-
noids and anthocyanes (22–24). However, no definite
evidence is available for any of these components.
In conclusion, even though some findings are not new,
this is one of the few papers assessing in the setting of
patients the role of various cofactors on the progression
of liver disease in alcoholics, and the use of an internal
control group may have avoided spurious associations.
Results indicate that alcohol intake interacts with hepa-
titis viruses in the progression of liver disease and, firstly,
the role of HBsAg positivity has been defined. Coffee
represents a modulator of alcoholic cirrhosis risk. In any
case, even if coffee may be considered to be protective,
the primary approach to the reduction of alcoholic
cirrhosis includes the avoidance or cessation of heavy
alcohol drinking.
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